The Valley Desk

NCT01313559 · Interventional trial

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Overall registry status Terminated

Phase 2

Conditions Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov